Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1CNS 1

Conditions

Lymphoma, Large B-Cell, Diffuse 4Lymphoma 4Small Cell Lung Carcinoma 3Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Optic Nerve Glioma 3Oligodendroglioma 3Leukemia, Myeloid, Acute 3Leukemia 3Central Nervous System Neoplasms 3Astrocytoma 3Sarcoma 2Medulloblastoma 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Leukemia, Lymphocytic, Chronic, B-Cell 2Familial ependymoma 2Drug-Related Side Effects and Adverse Reactions 2Burkitt Lymphoma 2Breast Neoplasms 2Wilms Tumor 1Thrombocytopenia 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Spinal Cord Neoplasms 1Rhabdoid Tumor 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1

Interventions

Rituximab 5Peripheral Blood Stem Cell Transplantation 3Lenalidomide 2Ipilimumab 2Etoposide 2Dasatinib 2Cyclophosphamide 2CTLA-4 Antigen 2tanespimycin 1sodium thiosulfate 1pegfilgrastim 1obatoclax 1ibrutinib 1fludarabine phosphate 1etoposide phosphate 1devimistat 1belinostat 1amuvatinib 1Vorinostat 1Vincristine 1Tacrolimus 1Sirolimus 1Razoxane 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Oxycodone 1Oxaliplatin 1Moxifloxacin 1Morphine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Intraocular Lymphoma × etoposide phosphate × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡